Amy Wakeham | executive |
Michael Farrell | executive |
Brett Sandercock | executive |
Margaret Kaczor | analyst |
Anthony Petrone | analyst |
Michael Matson | analyst |
Suraj Kalia | analyst |
Steven Wheen | analyst |
Saul Hadassin | analyst |
Mathieu Chevrier | analyst |
Matthew Taylor | analyst |
Lyanne Harrison | analyst |
Michael Polark | analyst |
Hello, and welcome to the ResMed Second Quarter Fiscal Year 2024 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Chief Investor Relations Officer, Amy Wakeham. Please go ahead, Amy.
Great. Thank you, Kevin.